![We’re buying more of this health-care company amid an overdone sell-off](https://newsology.co.in/wp-content/uploads/https://image.cnbcfm.com/api/v1/image/107357257-1704980167454-gettyimages-1923334243-em025859_2024011024645207.jpeg?v=1711024629&w=1920&h=1080)
We’re buying more of this health-care company amid an overdone sell-off
[ad_1] Shortly after the opening bell, we will be buying 140 shares of Abbott Laboratories at roughly $112. Following the trade, Jim Cramer’s Charitable Trust will own 700 shares of ABT, increasing our weighting in the portfolio to 2.42% from 1.95%. We are buying more Abbott Laboratories into its recent weakness as we continue to…